SCHEMBL13639642

SCHEMBL13639642

CC(C)(C)OC(=O)N[C@@H](C[C@H](Cc1ccc(OCCF)cn1)C(=O)OC(C)(C)C)C(=O)OC(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 1/20 0.41
ITGA2B P08514 1/20 0.41
MAPT P10636 4/20 0.36
ALDH1A1 P00352 2/20 0.36
KDM4E B2RXH2 2/20 0.36
GLA P06280 2/20 0.36
GAA P10253 2/20 0.36
TSHR P16473 1/20 0.36
HSD17B10 Q99714 1/20 0.36
HRH2 P25021 5/20 0.35
HRH1 P35367 5/20 0.35
P2RY2 P41231 1/20 0.35
NPSR1 Q6W5P4 3/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
PTPN1 P18031 2/20 0.35
POLB P06746 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
ACE P12821 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16387458 1.00 ITGB3 (0.41) ITGB3ITGA2BMAPTALDH1A1KDM4E
SCHEMBL13570708 1.00 ITGB3 (0.41) ITGB3ITGA2BMAPTALDH1A1KDM4E
SCHEMBL13570709 1.00 ITGB3 (0.41) ITGB3ITGA2BMAPTALDH1A1KDM4E
SCHEMBL13639697 0.93 MAPT (0.36) ITGB3ITGA2BMAPTALDH1A1KDM4E
SCHEMBL16387526 0.91 ITGB3 (0.41) ITGB3ITGA2BMAPTALDH1A1KDM4E
SCHEMBL16387460 0.91 ITGB3 (0.41) ITGB3ITGA2BMAPTALDH1A1KDM4E
SCHEMBL13570781 0.88 ITGB3 (0.48) ITGB3ITGA2BPTPN1ACEHDAC8
SCHEMBL13570779 0.88 ITGB3 (0.48) ITGB3ITGA2BPTPN1ACEHDAC8
SCHEMBL13571246 0.86 ITGB3 (0.53) ITGB3ITGA2BHRH2HRH1PTPN1
SCHEMBL13571248 0.86 ITGB3 (0.53) ITGB3ITGA2BHRH2HRH1PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9238631-B2 Radiolabeled amino acids for diagnostic imaging PIRAMAL IMAGING SA (CH) 2016-01-19 US disclosed
US-9238631-B2 Radiolabeled amino acids for diagnostic imaging PIRAMAL IMAGING SA (CH) 2016-01-19 US disclosed
US-20150011773-A1 RADIOLABELED AMINO ACIDS FOR DIAGNOSTIC IMAGING PIRAMAL IMAGING SA (CH) 2015-01-08 US disclosed
US-20150011773-A1 RADIOLABELED AMINO ACIDS FOR DIAGNOSTIC IMAGING PIRAMAL IMAGING SA (CH) 2015-01-08 US disclosed
EP-2520556-A1 Radiolabeled amino acids for diagnostic imaging Bayer Pharma Aktiengesellschaft (DE) 2012-11-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150011773-A1 RADIOLABELED AMINO ACIDS FOR DIAGNOSTIC IMAGING SLC1A5, SLC6A19, BCAT2 ITGB3 1794/4885ITGA2B 2819/4885MAPT 1039/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.